PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40628732,Glioblastoma at the crossroads: current understanding and future therapeutic horizons.,2025,Sujata Prasad,"MLM Medical Labs LLC, Oakdale, MN, USA.",gsingh@umn.edu.
40628625,"Expression of Kappa Myeloma Antigen (KMA) and Lambda Myeloma Antigen (LMA) on Malignant but Not Normal Plasma Cells Offers Novel Therapeutic Targets for Patients With Myeloma, Amyloidosis and Other Plasma Cell Dyscrasias.",2025,Thomas X Lemarchand; Luise Britz; Rosanne Dunn,"TPL Path Labs GmbH, StageBio Company, Freiburg im Breisgau 79111, Germany.; TPL Path Labs GmbH, StageBio Company, Freiburg im Breisgau 79111, Germany.; Haemalogix Ltd, Sydney, New South Wales 2001, Australia.",david.gottlieb@sydney.edu.au.
40628289,Understanding antibody-target antigen interactions and the avidity effect using mathematical modelling.,2025,Armin Sepp; James Yates,"Certara UK Limited, Sheffield, UK.; GSK plc, Stevenage, UK.",Not found
40628269,The costimulatory molecule ICOS limits memory-like properties and function of exhausted PD-1,2025,Tesia Bobrowski; Brad R Rosenberg,"Department of Microbiology, ISMMS, New York, NY 10029, USA.; Department of Microbiology, ISMMS, New York, NY 10029, USA.",alice.kamphorst@mssm.edu.
40628264,Neutralization of acyl coenzyme A binding protein for the experimental prevention and treatment of hepatocellular carcinoma.,2025,Sijing Li; Omar Motiño; Flavia Lambertucci; Jonathan Pol; Hui Chen; Long Pan; Sylvère Durand; Lucie Poupel; Christophe Klein; Léa Montégut; María Pérez-Lanzón; Gerasimos Anagnostopoulos; Uxia Nogueira-Recalde; Alexandra Cerone; Fanny Aprahamian; Yanbing Dong; Manuela Lizarralde-Guerrero; Enfu Xue; Peng Liu; Liwei Zhao; Hui Pan; Vincent Carbonnier; Sylvie Lachkar; Ester Gloria Saavedra Díaz; Chantal Desdouets; Sabine Colnot; Oliver Kepp; Isabelle Martins; Laurence Zitvogel; Jessica Zucman-Rossi; Guido Kroemer,"Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France; Faculté de Médecine, Université de Paris Saclay, Kremlin Bicêtre, Paris, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France.; Team ""Functional Genomics of Solid Tumors"", Centre de Recherche des Cordeliers, Inserm U1138, Université Paris Cité, Sorbonne Université, 75006 Paris, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France.; CHICS, Centre de Recherche des Cordeliers, Inserm U1138, Université Paris Cité, Sorbonne Université, Paris, France.; CHICS, Centre de Recherche des Cordeliers, Inserm U1138, Université Paris Cité, Sorbonne Université, Paris, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France; Grupo de Investigación en Reumatología (GIR), Instituto de Investigación Biomédica de A Coruña (INIBIC), Fundación Profesor Novoa Santos, A Coruña, Spain.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France; Faculté de Médecine, Université de Paris Saclay, Kremlin Bicêtre, Paris, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France; Faculté de Médecine, Université de Paris Saclay, Kremlin Bicêtre, Paris, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France; Faculté de Médecine, Université de Paris Saclay, Kremlin Bicêtre, Paris, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France; Departamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología, Instituto Universitario de Investigaciones Biomédicas y Sanitarias (IUIBS), Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.; Team Genomic Instability, Metabolism, Immunity and Liver Tumorigenesis Laboratory, Equipe Labellisée LIGUE 2023, Centre de Recherche des Cordeliers, Sorbonne Université, INSERM, Université de Paris, Paris, France.; Team ""Oncogenic functions of β-catenin Signaling in the Liver (ONCOLIV)"", Centre de Recherche des Cordeliers, Equipe Labellisée Par La Ligue Contre le Cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, Paris, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France.; Gustave Roussy Cancer Center, ClinicoBiome, 94805 Villejuif, France; Université Paris Saclay, Faculty of Medicine, 94270 Kremlin Bicêtre, France; Inserm U1015, Equipe Labellisée Par La Ligue Contre le Cancer, 94800 Villejuif, France; Center of Clinical Investigations in Biotherapies of Cancer (CICBT), Gustave Roussy, 94805 Villejuif, France.; Team ""Functional Genomics of Solid Tumors"", Centre de Recherche des Cordeliers, Inserm U1138, Université Paris Cité, Sorbonne Université, 75006 Paris, France; Institut du Cancer Paris CARPEM, Department of Biology, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.; Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, F-75006 Paris, France; Équipe Labellisée Par La Ligue Contre le Cancer, Institut Universitaire de France, Paris, France; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France; Institut du Cancer Paris CARPEM, Department of Biology, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. Electronic address: kroemer@orange.fr.",kroemer@orange.fr.
40627846,EML4-ALK rearrangement creates a distinctive myeloid cell-dominant immunosuppressive microenvironment in lung cancer.,2025,Yukari Nishito; Hideaki Mizuno; Yukiko Sonobe; Yoko Kayukawa; Toru Maruyama; Yukihiro Mizoguchi; Shigehisa Kitano; Risa Mitsumori; Kouichi Ozaki; Shumpei Niida; Kazuki Yasuda; Hiroyuki Tsunoda,"Chugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, Japan.; Chugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, Japan.; Chugai Pharmaceutical Co., Ltd., Yokohama City, Japan.; Chugai Pharmaceutical Co. Ltd., Yokohama, Kanagawa, Japan.; Roche (Switzerland), Basel, Basel-stadt, Switzerland.; Japanese Foundation For Cancer Research, Koto-ku, Tokyo, Japan.; Japanese Foundation For Cancer Research, Koto-ku, Tokyo, Japan.; National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.; National Center for Geriatrics and Gerontology, Obu, Japan.; National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.; National Center for Global Health and Medicine, Japan.; Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan.",Not found
40627813,RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE).,2025,Michael K Wong; Judith Michels; Jiaxin Niu; Tawnya Lynn Bowles; Caroline Gaudy-Marqueste; Praveen K Bommareddy; Junhong Zhu; Marcus Viana; Jeannie W Hou; Robert S Coffin,"Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.; Banner MD Anderson Cancer Center, Gilbert, AZ, USA.; Intermountain Medical Center, Murray, UT, USA.; Aix-Marseille Université, APHM, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, UM105, Hôpital Timone, CEPCM, Dermatology and Skin Cancer Department, Marseille, France.; Replimune, Inc., Woburn, MA, USA.; Replimune, Inc., Woburn, MA, USA.; Replimune, Inc., Woburn, MA, USA.; Replimune, Inc., Woburn, MA, USA.; Replimune, Inc., Woburn, MA, USA.",Not found
40627669,HPV vaccine uptake among adolescent girls in Nigeria: The complex role of caregivers' education.,2025,Ifeanyi Nsofor,"Family Health Initiative, Abuja, Nigeria.",Not found
40627448,NOTCH1 reverses immune suppression in small cell lung cancer through reactivation of STING.,2025,Barzin Y Nabet; Velimir Gayevskiy; Alberto Chiappori; David S Shames,"Genentech Inc., South San Francisco, United States of America.; Genentech Inc., South San Francisco, United States of America.; Thoracic Oncology Program, Moffitt Cancer Center, Tampa, United States of America.; Genentech Inc., South San Francisco, United States of America.",Not found
40627445,"SARC028 samples reveal an interplay between TGFβ, interferon signaling and low HLA class I expression as contributors to Ewing sarcoma checkpoint blockade resistance.",2025,Melissa Burgess,"U Pittsburgh, Pittsburgh, PA, United States.",Not found
40627401,Controlling T cell-tumor cell interaction with a biomimetic physical barrier for cancer immunotherapy.,2025,Yuxuan Zhang; Jinjin Wang; Guangchao Qing; Yongchao Wang; Xianlei Li; Ting Luo; Yi-Feng Wang; Lu Liu; Yufei Wang; Qiankun Ni; Shuyi Li; Junge Chen; Fangzhou Li; Xing-Jie Liang,"Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.",Not found
40626955,Design and Characterization of Prodrugged Anti-CTLA-4 Antibodies.,2025,Sayumi Yamazoe; Mary Huber; Srikanth Kotapati; Rahima Akter; Aarti Jashnani; Suprit Deol; Christine Bee; John Engelhart; Yam B Poudel; Stanley Krystek; Mohan Srinivasan; Arvind Rajpal; Yong Zhang; Pavel Strop; Chetana Rao; John Haugner,"Bristol-Myers Squibb Co, Discovery Biologics, 700 Bay road, 94063, Redwood city, UNITED STATES OF AMERICA.; Bristol Myers Squibb Co, Research and Development, UNITED STATES OF AMERICA.; Bristol-Myers Squibb Company, Research and Development, UNITED STATES OF AMERICA.; Bristol Myers Squibb Co, Research and Development, UNITED STATES OF AMERICA.; Bristol Myers Squibb Co, Research and Development, UNITED STATES OF AMERICA.; Bristol Myers Squibb Co, Research and Development, UNITED STATES OF AMERICA.; Bristol Myers Squibb Co, Research and Development, UNITED STATES OF AMERICA.; Bristol Myers Squibb Co, Research and Development, UNITED STATES OF AMERICA.; Bristol Myers Squibb Co, Research and Development, UNITED STATES OF AMERICA.; Bristol Myers Squibb Co, Research and Development, UNITED STATES OF AMERICA.; Bristol Myers Squibb Co, Research and Development, UNITED STATES OF AMERICA.; Bristol Myers Squibb Co, Research and Development, UNITED STATES OF AMERICA.; Bristol Myers Squibb Co, Research and Development, UNITED STATES OF AMERICA.; Bristol Myers Squibb Co, Research and Development, UNITED STATES OF AMERICA.; Bristol Myers Squibb Co, Research and Development, UNITED STATES OF AMERICA.; Bristol Myers Squibb Co, Research and development, UNITED STATES OF AMERICA.",Not found
40626883,Vγ9Vδ2 T Cells Express an Antitumor Profile Associated with Anti-PD-(L)1 Responses and Activation Defects Restored by Anti-BTN3A in Triple-Negative Breast Cancer.,2025,Stéphane Fattori; Laurent Gorvel; Marie-Sarah Rouvière; Samuel Granjeaud; Amira Ben Amara; Manon Richaud; Nicolas Boucherit; Grégoire Bellan; Jean-Jacques Fournié; Anne-Sophie Chrétien,"Centre de Recherche en Cancérologie de Marseille, Marseille, France.; Centre de Recherche en Cancérologie de Marseille, Marseille, France.; Centre de Recherche en Cancérologie de Marseille, Marseille, France.; Centre de Recherche en Cancérologie de Marseille, Marseille, France.; Centre de Recherche en Cancérologie de Marseille, Marseille, France.; Centre de Recherche en Cancérologie de Marseille, Marseille, France.; Centre de Recherche en Cancérologie de Marseille, Marseille, France.; Télécom Paris, France.; INSERM, Toulouse, France.; Inserm, Marseille, France.",Not found
40626667,Lights and shadows of microsatellite status characterization in gastrointestinal cancers in the era of cancer precision therapy.,2025,Paola Parente; Luisa Toffolatti,"Unit of Pathology, Fondazione IRCCS Ospedale Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Foggia, Italy.; Surgical Pathology Unit, ULSS2 Marca Trevigiana, Treviso, Italy.",Not found
40626281,Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models.,2025,Mathias Heikenwälder,"Division of Chronic Inflammation and Cancer, German Cancer Research Centre Heidelberg (DKFZ), Heidelberg, Germany.",Not found
40626041,Perspective on recent developments and challenges in regulatory and systems genomics.,2025,Alejandra Medina-Rivera,"Laboratorio Internacional de Investigación sobre el Genoma Humano, Universidad Nacional Autónoma de México, Santiago de Querétaro 76230, Mexico.",Not found
40626017,Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management.,2025,Rebecca Alexandra Dent; Veronique Kiak-Mien Tan; Frances Victoria F Que; Sun-Young Kong,"Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Department of Breast Surgery, Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Department of Internal Medicine and Oncology, St Luke's Medical Center, Quezon City and Global City, Metro Manila, Philippines.; Department of Laboratory Medicine and Genetic Counselling Clinic, National Cancer Center, Goyang, Gyeonggi-do, Republic of Korea.",Not found
40625771,A rare case of primary prostate melanoma with extensive secondaries: case report.,2025,Kumanan Jayaraman; Rejeesh Selvaganesan; Binitta Sherin,"Oncology, KIMS Health, TVM Main Road, Chukankadai, Nagercoil, 629003 India.; Surgical Gastroenterology, KIMS Health, TVM Main Road, Chukankadai, Nagercoil, 629003 India.; Pathology, KIMS Health, TVM Main Road, Chukankadai, Nagercoil, 629003 India.",Not found
40624367,"EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma.",2025,Sonja Zweegman; Niels W C J van de Donk; Elena Zamagni; Paula Rodriguez-Otero; Christoph Driessen; Michele Cavo; Mohamad Mohty; Jesus San-Miguel,"Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands.; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands.; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia ""Seràgnoli"", Bologna, Italy.; Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain.; Department of Medical Oncology and Hematology, HOCH Health Ostchweiz, St. Gallen, Switzerland.; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.; Centre de Recherche Saint-Antoine INSERM UMRs938, Sorbonne Université, Paris, France.; Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain.",eterpos@med.uoa.gr.
40624238,IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR,2025,Kenneth H Gouin; Hsiang-Han Chen; Aagam Shah; Carlos Eduardo de Andrea; Belén Navarro-Rubio; Irantzu Serrano-Mendioroz; Esther Navarro Manzano; Alexandra M Satty; Brady Rippon; Xi Kathy Zhou; Joseph M Scandura; Elena García-Martínez; Francisco Ayala de la Peña; María Esperanza Rodríguez-Ruiz; Víctor Sánchez-Margalet; Luis de la Cruz-Merino; Stephen L Shiao; Heather L McArthur; Simon R V Knott,"Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Department of Anatomy, Physiology and Pathology, Clínica Universidad de Navarra, Pamplona, Spain.; Department of Radiation Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain.; Centro Regional de Hemodonación, Murcia, Spain.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.; Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.; Department of Radiation Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Department of Medical Biochemistry, Molecular Biology and Immunology, Faculty of Medicine, Universidad de Sevilla, Sevilla, Spain.; Department of Medical Biochemistry, Molecular Biology and Immunology, Faculty of Medicine, Universidad de Sevilla, Sevilla, Spain.; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.",deadoc80@gmail.com.
40623886,"Platinum and etoposide chemotherapy, durvalumab with thoracic radiotherapy in the first-line treatment of patients with extensive-stage small-cell lung cancer: CHEST-RT (TROG 20.01) Trial - protocol for a phase II study.",2025,Sagun Parakh; Harriet Gee; Courtney Wheeler; Bridget Rooney; Rebecca Montgomery; Susan Harden; Laurel Schmidt,"Olivia Newton-John Cancer Centre at Austin Health, Heidelberg, Victoria, Australia.; Radiation Oncology Network, Western Sydney Local Health District, Sydney, New South Wales, Australia.; Trans Tasman Radiation Oncology Group, Waratah, New South Wales, Australia.; Trans Tasman Radiation Oncology Group, Waratah, New South Wales, Australia.; Trans Tasman Radiation Oncology Group, Waratah, New South Wales, Australia.; Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; St George Cancer Care Centre, Kogarah, Sydney, Australia.",eric.hau@health.nsw.gov.au.
40623769,Role of microbiome in cancer progression.,2025,Akshay Basi,"NC Flow Cytometry and Cellular Imaging Core Facility, MD Anderson Cancer Center, Houston, TX, United States.",micro9sadhna@gmail.com.
40623767,The role of microbiome in CAR-T cell therapy.,2025,Travis D Kerr; Daniel J McGrail,"Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, United States.; Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, United States.",Sbentebibel@mdanderson.org.
40623718,"Authors response to ""Letter to the Editor"": ""Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types"".",2025,Ryon P Graf; David R Gandara,"Foundation Medicine Inc, San Diego, California, USA rgraf@foundationmedicine.com.; Cancer Ctr So./Div of Hem and Onc, UC Davis Department of Medicine, Sacramento, California, USA.",rgraf@foundationmedicine.com.
40623716,Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapy.,2025,Florian Rothweiler; Jindrich Cinatl; Martin Michaelis,"Dr Petra Joh-Haus, Frankfurter Stiftung für krebskranke Kinder, Frankfurt (Main), Germany.; Dr Petra Joh-Haus, Frankfurter Stiftung für krebskranke Kinder, Frankfurt (Main), Germany.; Dr Petra Joh-Haus, Frankfurter Stiftung für krebskranke Kinder, Frankfurt (Main), Germany.",Evelyn@Ullrichlab.de.
40623177,Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy.,2025,Zia Khan; Jeffrey Bruce; Cindy Yang; Stephenie Prokopec; Trevor Pugh; Thomas John; Geoffrey Peters,"Genentech, South San Francisco, CA 94080-4990.; Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.; Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.; Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.; Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Canberra Region Cancer Centre, Garran, ACT 2605, Australia.",Not found
40623115,Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trials.,2025,Christina E Barkauskas; Helene C Highbarger; Lindsey M Leither; Magdalena Ardelt; J Scott Overcash; Hassan Taha; David Vallee,"Department of Medicine, Division of Pulmonary and Critical Medicine, Duke Medicine, Durham, North Carolina, United States of America.; Virus Isolation and Serology Laboratory, Frederick National Laboratory, Applied and Developmental Directorate, Frederick, Maryland, United States of America.; Intermountain Medical Center, Salt Lake City, Utah, United States of America.; Ralph H Johnson VA Medical Center, Charleston, South Carolina, United States of America.; Velocity Clinical Research, San Diego, California, United States of America.; Stormont Vail Health, Vail, Colorado, United States of America.; Frederick National Laboratory for Cancer Research/Leidos Biomedical Research, Frederick, Maryland, United States of America.",Not found
40622715,Multilevel Intervention and Human Papillomavirus Vaccination Disparities: A Secondary Analysis of a Cluster Randomized Trial.,2025,Wei Yi Kong; Lila J Finney Rutten; Jennifer L St Sauver; Gregory D Jenkins; Joan M Griffin; Robert M Jacobson,"Division of Epidemiology, Mayo Clinic, Rochester, Minnesota.; Division of Epidemiology, Mayo Clinic, Rochester, Minnesota.; Division of Epidemiology, Mayo Clinic, Rochester, Minnesota.; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.; Division of Health Care Delivery Research and Robert D. and Patricia E. Kern Center for Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota.; Division of Epidemiology, Mayo Clinic, Rochester, Minnesota.",Not found
40622275,Impact of Glucocorticoids on Immune Checkpoint Inhibitor Efficacy and Circulating Biomarkers in Non-Small Cell Lung Cancer Patients.,2025,Ryutaro Kajihara; Takaaki Oba; Eihab Abdelfatah; Joy Sarkar; Junko Matsuzaki,"Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, New York.",Not found
40622253,Novel Autologous Regulatory T-Cell Therapy Ameliorates DSS-Induced Colitis in Humanized Mice.,2025,Md Jabed Khan; Yoo Jin Lee; Su Yeon Lee; Young Mo Kang,"Preclina Inc., 719 & 1302, Teratower B, 167, Songpa-daero, Songpa-gu, Seoul, South Korea.; Preclina Inc., 719 & 1302, Teratower B, 167, Songpa-daero, Songpa-gu, Seoul, South Korea.; Preclina Inc., 719 & 1302, Teratower B, 167, Songpa-daero, Songpa-gu, Seoul, South Korea.; Preclina Inc., 719 & 1302, Teratower B, 167, Songpa-daero, Songpa-gu, Seoul, South Korea.",Not found
